학술논문

Enzalutamide, an androgen receptor antagonist, enhances myeloid cell-mediated immune suppression and tumor progression
Document Type
Article
Source
In: Cancer Immunology Research. (Cancer Immunology Research, 1 September 2020, 8(9):1215-1227)
Subject
Language
English
ISSN
23266074
23266066